Koehler U, Reinke C, Sibai E, Hildebrandt O, Sohrabi K, Dette F, Grimm W
Klinik für Innere Medizin, SP Pneumologie, Intensiv- und Schlafmedizin, Philipps-Universität Marburg, Marburg.
Dtsch Med Wochenschr. 2011 Dec;136(50):2622-8. doi: 10.1055/s-0031-1292852. Epub 2011 Dec 7.
Obstructive sleep apnea and central sleep apnea with Cheyne-Stokes respiration are associated with an increased risk of cardiac arrhythmia. Apnea- associated arrhythmia may contribute to sudden cardiac death and premature mortality in those patients. Both forms of sleep apnea excert strong modulatory effects on the autonomic system with a special autonomic profile. Profound vagal activity is leading to bradyarrhythmias, and sypathico-excitation to tachyarrhythmias. Atrial fibrillation and ventricular arrhythmias in obstructive and central sleep apnea patients are mainly found in combination with cardiovascular comorbidity (coronary heart disease, hypertensive heart disease, chronic heart failure). Bradyarrhythmias in OSA are induced by a cardioinhibitory vagal reflex due to obstructed airway. CPAP-therapy has been demonstrated to reduce arrhythmias.
阻塞性睡眠呼吸暂停以及伴有陈-施呼吸的中枢性睡眠呼吸暂停与心律失常风险增加相关。与呼吸暂停相关的心律失常可能导致这些患者的心源性猝死和过早死亡。两种形式的睡眠呼吸暂停对自主神经系统均有强烈的调节作用,具有特殊的自主神经特征。深度迷走神经活动会导致缓慢性心律失常,而交感神经兴奋则会导致快速性心律失常。阻塞性和中枢性睡眠呼吸暂停患者的心房颤动和室性心律失常主要与心血管合并症(冠心病、高血压性心脏病、慢性心力衰竭)同时出现。阻塞性睡眠呼吸暂停中的缓慢性心律失常是由气道阻塞引起的心脏抑制性迷走神经反射所致。已证实持续气道正压通气治疗可减少心律失常。